Detalhe da pesquisa
1.
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer.
Int J Cancer
; 148(3): 748-758, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045100
2.
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
World J Urol
; 39(3): 829-837, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361874
3.
Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
Med Mol Morphol
; 54(2): 156-165, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33373033
4.
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
Mol Med
; 26(1): 24, 2020 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32143573
5.
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
World J Surg Oncol
; 18(1): 128, 2020 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534597
6.
5q21 deletion is often heterogeneous in prostate cancer.
Genes Chromosomes Cancer
; 58(8): 509-515, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623509
7.
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.
Mol Carcinog
; 58(12): 2306-2315, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31545001
8.
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.
BMC Cancer
; 19(1): 944, 2019 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606028
9.
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer.
Genes Chromosomes Cancer
; 57(10): 504-512, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29923647
10.
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
BMC Cancer
; 18(1): 1106, 2018 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419865
11.
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
BMC Cancer
; 18(1): 37, 2018 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29304771
12.
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer.
BMC Cancer
; 18(1): 612, 2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855276
13.
Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer.
World J Urol
; 36(6): 877-882, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427004
14.
Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancer.
Exp Mol Pathol
; 105(1): 50-56, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29803408
15.
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
Carcinogenesis
; 38(1): 19-27, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803051
16.
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.
Prostate
; 77(15): 1528-1538, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929505
17.
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion.
Mol Carcinog
; 56(9): 2135-2145, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467610
18.
Prevalence of ßIII-tubulin (TUBB3) expression in human normal tissues and cancers.
Tumour Biol
; 39(10): 1010428317712166, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022485
19.
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
BJU Int
; 120(3): 365-376, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295933
20.
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
Int J Mol Sci
; 18(2)2017 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146062